Stock AXSM AXSOME THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Axsome Therapeutics, Inc.

Equities

AXSM

US05464T1043

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-24 pm EDT 		5-day change 1st Jan Change
75.19 USD +1.36% Intraday chart for Axsome Therapeutics, Inc. -1.76% -5.53%
May. 16 Transcript : Axsome Therapeutics, Inc. Presents at Bank of America Health Care Conference 2024, May-16-2024 08:00 AM
May. 08 Mizuho Securities Adjusts Price Target on Axsome Therapeutics to $106 From $109, Maintains Buy Rating MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Biopharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
AXSOME THERAPEUTICS, INC. Stock Axsome Therapeutics, Inc.
 3.57B -
CSL LIMITED Stock CSL Limited
 90.02B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
 39.15B
BIOGEN INC. Stock Biogen Inc.
 31.71B
UCB Stock UCB
 26.47B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
 14.34B
  1. Stock Market
  2. Equities
  3. AXSM Stock
  4. Charts Axsome Therapeutics, Inc.
  5. Sector Chart